The invention discloses a
medicine for treating
acute leukemia. The
medicine, as a traditional Chinese medicinal agent, is characterized by being prepared from the following twelve traditional Chinese medicines: cornu bubali, pseudobulbus cremastrae seu pleiones, spreading
hedyotis herb,
herba scutellariae barbatae, radix arnebiae seu lithospermi, rhizoma curcumae,
indigo naturalis
powder, radix rehmanniae recen, radix paeoniae rubra, radix astragali, radix scrophulariae and
turtle shell; and the proportions of the various traditional Chinese medicines in parts by weight are as follows: 25-35 parts of the cornu bubali, 17-23 parts of the pseudobulbus cremastrae seu pleiones, 17-23 parts of the spreading
hedyotis herb, 17-23 parts of the
herba scutellariae barbatae, 17-23 parts of the radix arnebiae seu lithospermi, 8-12 parts of the rhizoma curcumae, 8-12 parts of the
indigo naturalis
powder, 17-23 parts of the radix rehmanniae recen, 17-23 parts of the radix paeoniae rubra, 17-23 parts of the radix astragali, 17-23 parts of the radix scrophulariae and 17-23 parts of the
turtle shell. The
medicine disclosed by the invention has the characteristics of being relatively good in
treatment effect, short in treatment course, not easy for recurrence, free from toxic and side effects and relatively low in treatment expense. Upon clinical
verification, the medicine disclosed by the invention is relatively good in functions of clearing away heat and toxic materials, promoting
blood circulation and removing
blood stasis, and the medicine has a
curative effect on attacking
pathogen and strengthening healthy energy; and compared with an existing medicine, the medicine disclosed by the invention not only has the characteristics of being relatively good in
treatment effect and short in treatment course, but also has the advantages of being free from toxic and side effects and low in treatment expense.